@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-MN74TSPW-8
  skos:prefLabel "Oxazocines"@en, "Oxazocines"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-X5M1JKSS-C .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-X5M1JKSS-C
  dc:created "1974-11-19"^^xsd:date ;
  dc:modified "2017-05-24"^^xsd:date ;
  skos:broader jvr:-MN74TSPW-8 ;
  mesh:allowableQualifier jvr:-L6C0XPHT-4, jvr:-M63HSDM7-1, jvr:-Q3979798-W, jvr:-H7K65Q8S-Z, jvr:-NB0XHT3S-N, jvr:-FWD2BGQ0-9, jvr:-G30ZJ446-J, jvr:-CB30NGKB-3, jvr:-HQRFT0C6-B, jvr:-S0CS1X5R-5, jvr:-T9HQD7ST-J, jvr:-THHNVC7V-3, jvr:-TJHVZCRZ-0, jvr:-NHL3D2X0-S, jvr:-D0F21513-5, jvr:-SBNWSM1T-R, jvr:-BT300B3G-Q, jvr:-W6SQV79N-S, jvr:-G4R176S9-J, jvr:-R0ZCQ8X6-J, jvr:-R3QWLHRG-V, jvr:-NFTHND7Q-8, jvr:-XV06LPML-W, jvr:-WK5F724J-1, jvr:-NKM836P1-M ;
  a skos:Concept, mesh:Descriptor ;
  skos:altLabel "23327-57-3 (HCl)"@fr, "23327-57-3 (HCl)"@en, "1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-"@en, "1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-"@fr, "4UP8060B7J"@fr, "4UP8060B7J"@en, "685J48E13W"@en, "685J48E13W"@fr, "13669-70-0 (Nefopam)"@fr, "13669-70-0 (Nefopam)"@en ;
  skos:inScheme jvr: ;
  skos:hiddenLabel "Chlorhydrate de néfopam"@fr, "Ajan"@en, "Acupan"@en, "Silentan Nefopam"@en, "Nefopam Hydrochloride"@en, "Fenazoxine"@en ;
  dc:established "1991-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D009340> ;
  skos:definition "Non-narcotic analgesic chemically similar to ORPHENADRINE. Its mechanism of action is unclear. It is used for the relief of acute and chronic pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p26)"@en ;
  skos:prefLabel "Néfopam"@fr, "Nefopam"@en ;
  mesh:pharmacologicalAction jvr:-DPQ29XMV-Q .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-DPQ29XMV-Q
  skos:prefLabel "Analgesics, Non-Narcotic"@en, "Analgésiques non narcotiques"@fr ;
  a mesh:Descriptor, skos:Concept .